SA

Stephane Durant Des Aulnois

Chief Financial Officer at Corteria Pharmaceuticals

Stephane Durant Des Aulnois began their work experience in 2004 as an Equity Research Analyst at Exane. Stephane then moved on to Calyon Americas in 2006 where they worked in Credit Analysis. In 2007, they joined LaSalle Investment Management as part of the Private Equity Acquisitions team. In 2011, they joined Ipsen and worked in various roles including Investor Relations Director, Vice President Head of Investor Relations, and CFO Iberia (Spain and Portugal) until 2019. From 2019 to 2023, Stephane served as the Chief Financial Officer at LYSOGENE. Currently, they hold the position of Chief Financial Officer at Corteria Pharmaceuticals.

Stephane Durant Des Aulnois began their education at Fenelon but no specific degree or field of study is mentioned. From 2000 to 2004, they attended Université Paris Dauphine - PSL and earned a degree in Gestion. In 2005, they enrolled at The London School of Economics and Political Science (LSE) and pursued a Master of Science in Accounting & Finance, which they completed in 2006. Finally, they completed an Executive Education program at Harvard Business School in 2018, although the specific field of study is not provided.

Links

Previous companies

Ipsen logo


Teams

This person is not in any teams